Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P F Searle

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
The Journal of General Virology|July 1, 1993
Dilated heart failure in transgenic mice expressing the Epstein-Barr virus nuclear antigen-leader proteinD S Huen, A Fox, P Kumar, et al.
Cancer Research|February 10, 2000
Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vectorJ P Latham, P F Searle, V Mautner, et al.
Human Gene Therapy|August 31, 1999
Improved titers of retroviral vectors from the human FLYRD18 packaging cell line in serum- and protein-free mediumP A Gerin, M G Gilligan, P F Searle, et al.
Gene Therapy|February 16, 2007
Direct positive selection for improved nitroreductase variants using SOS triggering of bacteriophage lambda lytic cycleC P Guise, J I Grove, E I Hyde, et al.
Molecular and Cellular Endocrinology|June 1, 1983
Rapid estrogen metabolism and vitellogenin gene expression in Xenopus hepatocyte culturesM P Tenniswood, P F Searle, A P Wolffe, et al.
The Journal of General Virology|May 1, 1994
Stomach cancer in transgenic mice expressing human papillomavirus type 16 early region genes from a keratin promoterP F Searle, D P Thomas, K B Faulkner, et al.
Journal of Molecular Biology|August 9, 2001
The structure of Escherichia coli nitroreductase complexed with nicotinic acid: three crystal forms at 1.7 A, 1.8 A and 2.4 A resolutionA L Lovering, E I Hyde, P F Searle, et al.
Molecular Medicine Today|February 1, 2000
Gene therapy strategies for colon cancerG A Chung-Faye, D J Kerr, L S Young, et al.
British Journal of Cancer|May 21, 2009
E. coli NfsA: an alternative nitroreductase for prodrug activation gene therapy in combination with CB1954S O Vass, D Jarrom, W R Wilson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1984
A 12-base-pair DNA motif that is repeated several times in metallothionein gene promoters confers metal regulation to a heterologous geneG W Stuart, P F Searle, H Y Chen, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
The Journal of General Virology|July 1, 1993
Dilated heart failure in transgenic mice expressing the Epstein-Barr virus nuclear antigen-leader proteinD S Huen, A Fox, P Kumar, et al.
Cancer Research|February 10, 2000
Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vectorJ P Latham, P F Searle, V Mautner, et al.
Human Gene Therapy|August 31, 1999
Improved titers of retroviral vectors from the human FLYRD18 packaging cell line in serum- and protein-free mediumP A Gerin, M G Gilligan, P F Searle, et al.
Gene Therapy|February 16, 2007
Direct positive selection for improved nitroreductase variants using SOS triggering of bacteriophage lambda lytic cycleC P Guise, J I Grove, E I Hyde, et al.
Molecular and Cellular Endocrinology|June 1, 1983
Rapid estrogen metabolism and vitellogenin gene expression in Xenopus hepatocyte culturesM P Tenniswood, P F Searle, A P Wolffe, et al.
The Journal of General Virology|May 1, 1994
Stomach cancer in transgenic mice expressing human papillomavirus type 16 early region genes from a keratin promoterP F Searle, D P Thomas, K B Faulkner, et al.
Journal of Molecular Biology|August 9, 2001
The structure of Escherichia coli nitroreductase complexed with nicotinic acid: three crystal forms at 1.7 A, 1.8 A and 2.4 A resolutionA L Lovering, E I Hyde, P F Searle, et al.
Molecular Medicine Today|February 1, 2000
Gene therapy strategies for colon cancerG A Chung-Faye, D J Kerr, L S Young, et al.
British Journal of Cancer|May 21, 2009
E. coli NfsA: an alternative nitroreductase for prodrug activation gene therapy in combination with CB1954S O Vass, D Jarrom, W R Wilson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1984
A 12-base-pair DNA motif that is repeated several times in metallothionein gene promoters confers metal regulation to a heterologous geneG W Stuart, P F Searle, H Y Chen, et al.
Pageof 4